Photodynamic Therapy Derived Personalized Whole Cell Tumor Vaccine Prevents Postsurgery Tumor Recurrence and

Chunyu Yang1, Yitong Jiang2, Kaixin Zhang1

  • 1Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, China.

Insights

A novel photodynamic therapy (PDT) method creates personalized tumor vaccines (TVs) from patient tissues, bypassing antigen identification. This approach effectively suppresses tumor recurrence and metastasis by inducing potent immune responses.

Area of Science:

  • Oncology
  • Immunology
  • Biomedical Engineering

Background:

  • Traditional tumor-specific antigen (TSA) identification for vaccine fabrication is time-consuming and labor-intensive.
  • Photodynamic therapy (PDT) offers potential for cancer treatment but faces challenges with light penetration.
  • Personalized immunotherapy requires efficient and accessible methods for vaccine development.

Purpose of the Study:

  • To develop a versatile, photodynamic therapy (PDT)-based method for constructing whole-tumor antigen tumor vaccines (TVs) from resected tumor tissues.
  • To enable personalized immunotherapy by bypassing the need for identifying specific tumor antigens (TSAs).
  • To investigate the efficacy of the developed TV in suppressing postsurgery tumor recurrence and metastasis.

Main Methods:

  • Fabrication of mucoadhesive nanoparticles containing a photosensitizer.
  • Co-incubation of nanoparticles with tumor cells obtained from cytoreduction surgery.
  • Irradiation with a 405 nm laser to induce immunogenic cell death and TSA release.

Main Results:

  • The PDT-based method successfully induced potent immunogenic cell death in cancer cells.
  • The prepared tumor vaccines (TVs) released tumor-specific antigens (TSAs), activating robust immune responses.
  • The TVs demonstrated efficient suppression of postsurgery tumor recurrence and metastasis.
  • The TVs showed synergistic effects when combined with immunoadjuvants, chemotherapeutics, and immune checkpoint blockers.

Conclusions:

  • A versatile PDT-based strategy enables the efficient fabrication of personalized whole-cell tumor vaccines, overcoming limitations of traditional methods.
  • This approach facilitates the clinical translation of PDT by providing a method for vaccine generation from resected tumor tissue.
  • The developed tumor vaccines (TVs) offer a promising platform for personalized immunotherapy, alone or in combination therapies.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K